PS1
Featured Poster Session I: International Efforts in Gynecologic Cancer
Saturday, March 22, 2014: 2:00 PM-3:00 PM
Room 13-16 (Tampa Convention Center)
Description:
Featured Poster Session Moderator: Ram Eitan, MD, Rabin Medical Center, Sackler School of Medicine, Tel Aviv University, Petah Tikva, Israel
2:00 PM
Moderator Introductions
R. Eitan
Rabin Medical Center, Sackler School of Medicine, Tel Aviv University, Petah Tikva, Israel
2:05 PM
External validation of an all-stage ovarian cancer nomogram: is BRCA status more predictive than family history?
B. Cormier1, J. N. Barlin2, O. Charette1, L. Kou3, C. Yu3, M. W. Kattan3, D. S. Chi2 and D. M. Provencher1
1Centre Hospitalier de l’Université de Montréal, Montreal, QC, Canada, 2Memorial Sloan-Kettering Cancer Center, New York, NY, 3The Cleveland Clinic, Cleveland, OH
2:07 PM
Increased incidence and poor prognosis of breast cancer in postmenopausal women with high body mass index attending a mammography screening program in the province of Modena (Italy)
F. Sebastiani1, L. Cortesi1, M. Sant2, V. Lucarini1, C. Cirilli1, E. De Matteis1, I. Marchi1, R. Negri1, E. Gallo1 and M. Federico1
1University of Modena and Reggio Emilia, Modena, Italy, 2National Tumor Institute, Milano, Italy
2:11 PM
Discussant
R. Eitan
Rabin Medical Center, Sackler School of Medicine, Tel Aviv University, Petah Tikva, Israel
2:18 PM
Radical trachelectomy in early-stage cervical cancer: is minimally invasive surgery the new standard of care?
G. J. Rendón1, R. Pareja1, M. A. Vieira2, A. M. Nick3, M. F. Munsell3, L. M. Echeverri1, K. M. Schmeler3, M. Frumovitz3, P. F. Escobar4 and P. T. Ramirez3
1Instituto de Cancerología - Las Américas, Medellín, Colombia, 2Barretos Cancer Hospital, Barretos, Brazil, 3The University of Texas MD Anderson Cancer Center, Houston, TX, 4The Cleveland Clinic Foundation, Cleveland, OH
2:20 PM
A phase III randomized clinical trial of laparoscopic (TLRH) or robotic radical hysterectomy (RRH) versus abdominal radical hysterectomy (ARH) in patients with early-stage cervical cancer: preliminary quality-of-life outcomes
A. Obermair1, M. Frumovitz2, V. Gebski3, M. Janda4, J. Baker4, R. Pareja5 and P. T. Ramirez2
1Queensland Centre for Gynaecological Cancer, Herston, Australia, 2The University of Texas MD Anderson Cancer Center, Houston, TX, 3NHMRC Clinical Trials Centre, Sydney, Australia, 4Institute of Health Biomedical Innovation (IHBI), Brisbane, Australia, 5Instituto de Cancerología - Las Américas, Medellín, Colombia
2:22 PM
Long-term outcomes and survival prognostic factors in patients with positive nodes treated by neoadjuvant chemotherapy + radical surgery + adjuvant chemotherapy in locally advanced cervical cancer
D. D. Luvero, C. De Cicco Nardone, R. Ricciardi, F. Guzzo, S. Capriglione, G. Scaletta, F. Linciano, M. Li Destri, A. Arena and R. Angioli
University Campus Bio-Medico of Rome, Rome, Italy
2:24 PM
Prognostic value of pretreatment total-lesion glycolysis calculated by 18F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with locally advanced cervical cancer
J. H. Hong1, J. W. Kim2, J. Y. Song3, S. Kim4, J. K. Lee1 and N. W. Lee2
1Guro Hospital, Korea University College of Medicine, Seoul, South Korea, 2Ansan Hospital Korea University College of Medicine, Ansan, South Korea, 3Korea University College of Medicine, Seoul, South Korea, 4Guro Hospital College of Medicine Korea University, Seoul, South Korea
2:28 PM
Discussant
C. E. M. D. C. Andrade
Barretos Cancer Hospital, Barretos, Brazil
2:35 PM
Triage of women with negative cytology and positive high-risk human papillomavirus (HPV) DNA testing: an analysis of data from the SHENCCAST (Shenzhen Cervical Cancer Screening Program) II/III studies
S. K. Goodrich1, R. G. Pretorius2, H. Du3, R. Wu3 and J. L. Belinson1
1The Cleveland Clinic Foundation, Cleveland, OH, 2Southern California Permanente Medical Group - Fontana, Fontana, CA, 3Peking University Shenzhen Hospital, Shenzhen, China
2:39 PM
Cost-effectiveness of selective lymphadenectomy based on a preoperative prediction model in patients with endometrial cancer
J. Y. Lee1, J. W. Kim1, Y. W. Jeon2, K. Kim3, S. Kang4 and S. M. Park1
1Seoul National University, Seoul, South Korea, 2Korean Health Promotion Foundation, Seoul, South Korea, 3Seoul National University Bundang Hospital, SeoungNam, South Korea, 4National Cancer Center, Ilsan, South Korea
2:41 PM
The impact of body mass index on radiotherapy technique in patients with early-stage endometrial cancer: a single-center dosimetric study
G. Yavas1, C. Yavas2, O. S. Kerimoglu1 and C. Celik3
1Selcuk University, Konya, Turkey, 2Konya Training and Research Hospital, Konya, Turkey, 3Selçuk University, Konya, Turkey
2:43 PM
Discussant
L. T. Chuang
Icahn School of Medicine at Mount Sinai, New York, NY
2:48 PM
Question & Floor Discussion
